GlycoMira Therapeutics is developing therapeutics for Mucosal Diseases. Current R&D focus on mitigating radiation-induced injuries (Oral Mucositis & Acute Radiation Syndrome) and chronic rhinosinusitis.
+1 801-649-3999
675 Arapeen Drive
Salt Lake City, 84108
GlycoMira Therapeutics Inc.’s CEO is Tom Heath
GlycoMira Therapeutics Inc.’s CFO is Tom Heath
GlycoMira Therapeutics Inc.’s HQ is located at 675 Arapeen Drive, Salt Lake City
GlycoMira Therapeutics Inc.’s phone number is +1 801-649-3999
GlycoMira Therapeutics Inc.’s official website is glycomira.com
GlycoMira Therapeutics Inc.’s revenue is $1M - $5M
GlycoMira Therapeutics Inc. has 11 - 50 employees
GlycoMira Therapeutics Inc. is in the industry of: Pharmaceuticals